Albert Health received a total seed investment of $1 million from investors which included Sabancı Ventures, Akportfolio and EGIAD. Albert Health aims to accelerate clinical validation studies with this investment. The startup aims to expand its multi-chronic disease management platform to overseas markets, particularly in the UK.
Albert Health is a voice command and artificial intelligence-based digital health platform that enables patients to manage their chronic diseases. The startup has a vision to become a global digital disease management company. Albert Health is currently developing disease management and telehealth programs with multinational pharmaceutical companies. Founded in 2018, the company currently serves to more than 100,000 patients.
Also see: GittiGidiyor Shutdowns After 20 Years
“As the Sabancı Group, we continue our investments in digital technologies without slowing down as part of our ‘new economy’ oriented growth strategy. We make these investments in initiatives that we believe will shape the future. On the one hand, we fulfill our responsibility to our shareholders. On the other hand, as we stated in our Community Promise, we contribute to our purpose for a more sustainable life with the power of digital technologies. Within the scope of this strategy, we will continue to support pioneering ideas and initiatives that have the potential to create global value and whose influence exceeds the borders of any country.”
Sabancı Holding Strategy and Business Development Group President Gökhan Eyigün